Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

The Use of Biokinetics and in Vitro Methods in Toxicological Risk Evaluation

The Use of Biokinetics and in Vitro Methods in Toxicological Risk Evaluation ATLA 24 473-497 1996 473 The Use Of Biokinetics and In Vitro Methods in Toxicological Risk Evaluation 1 2 The Report and Recommendations of ECVAM Workshop 15 • 4 5 6 Bas J. Blaauboer, Martin K. Bayliss, Jose V. Castell, Chris T.A. Evelo, 8 9 7 10 John M. Frazier, Kees Groen, Michael Giilden, Andre Guillouzo, 11 2 3 Arendina M. Hissink, J. Brian Houston,l Gunnar Johanson,l Joost de 14 15 Jongh, Gregory L. Kedderis, Christoph A. Reinhardt, Johannes J.M. van de Sandt and Giovanna Semino RITOX, Utrecht University, 3508 TD Utrecht, The Netherlands; Department of Bioanalysis and Drug Metabolism, Glaxo Wellcome, Park Road, Ware, Herts. SG12 ODP, UK; Unidad de Hepatologia Experimental, Hospital Universitario La Fe, Avda de Campanar 21, 46009 Valencia, Spain; Department of Pharmacology, Section of Toxicology, University of Limburg, 6200 MD Maastricht, The Netherlands; US Air Force, Armstrong Laboratory, Wright Patterson Air Force Base, OH 45433, USA; Department of Clinical . Pharmacokinetics, Janssen Research Foundation, Turnhoutseweg 30, 2340 Beerse, Belgium; Cell Toxicology Section, Institute of Toxicology, University of Kiel, Weimarer Strasse 8, 24106 Kiel, Germany; INSERM U49, Unite de Recherches Hepatologiques, H6pital de Pontchaillou, 35033 Rennes Cedex, France; Toxicolofl Division, TNO Nutrition and Food Research http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Alternatives to Laboratory Animals SAGE

Loading next page...
 
/lp/sage/the-use-of-biokinetics-and-in-vitro-methods-in-toxicological-risk-S6UMoAERRG

References (76)

Publisher
SAGE
Copyright
© 1996 Fund for the Replacement of Animals in Medical Experiments
ISSN
0261-1929
eISSN
2632-3559
DOI
10.1177/026119299602400408
Publisher site
See Article on Publisher Site

Abstract

ATLA 24 473-497 1996 473 The Use Of Biokinetics and In Vitro Methods in Toxicological Risk Evaluation 1 2 The Report and Recommendations of ECVAM Workshop 15 • 4 5 6 Bas J. Blaauboer, Martin K. Bayliss, Jose V. Castell, Chris T.A. Evelo, 8 9 7 10 John M. Frazier, Kees Groen, Michael Giilden, Andre Guillouzo, 11 2 3 Arendina M. Hissink, J. Brian Houston,l Gunnar Johanson,l Joost de 14 15 Jongh, Gregory L. Kedderis, Christoph A. Reinhardt, Johannes J.M. van de Sandt and Giovanna Semino RITOX, Utrecht University, 3508 TD Utrecht, The Netherlands; Department of Bioanalysis and Drug Metabolism, Glaxo Wellcome, Park Road, Ware, Herts. SG12 ODP, UK; Unidad de Hepatologia Experimental, Hospital Universitario La Fe, Avda de Campanar 21, 46009 Valencia, Spain; Department of Pharmacology, Section of Toxicology, University of Limburg, 6200 MD Maastricht, The Netherlands; US Air Force, Armstrong Laboratory, Wright Patterson Air Force Base, OH 45433, USA; Department of Clinical . Pharmacokinetics, Janssen Research Foundation, Turnhoutseweg 30, 2340 Beerse, Belgium; Cell Toxicology Section, Institute of Toxicology, University of Kiel, Weimarer Strasse 8, 24106 Kiel, Germany; INSERM U49, Unite de Recherches Hepatologiques, H6pital de Pontchaillou, 35033 Rennes Cedex, France; Toxicolofl Division, TNO Nutrition and Food Research

Journal

Alternatives to Laboratory AnimalsSAGE

Published: Aug 1, 1996

There are no references for this article.